Efficacy and tolerability of multitarget therapy with NHMX for systemic lupus erythematosus
Efficacy and tolerability of multitarget therapy with NHMX for systemic lupus erythematosus
systemic lupus erythematosus
NHMX:One kind of non-steroid anti-inflammatory drugs combines with hydroxychloroquinesulfate(=200mg/bid) and methotrexate(7.5-20mg/w), with addition of glucocorticoid (=0.5mg/kg·d) or cyclosporine (maintaining the drug concentration between 30-90ug/l);control:hydroxychloroquinesulfate(=200mg/bid) and methotrexate(7.5-20mg/w), with addition of glucocorticoid (=0.5mg/kg·d) or cyclosporine(maintaining the drug concentration between 30-90ug/l); NHMX:One kind of non-steroid anti-inflammatory drugs combines with hydroxychloroquinesulfate(=200mg ...
The Third Affiliated Hospital, Southern Medical University
Multicenter Study Assessing the Efficacy & Safety of Hydroxychloroquine Sulfate in Patients With Systemic Lupus Erythematosus or Cutaneous Lupus Erythematosus With Active Lupus Erythematosus Specific Skin Lesion Multicenter Study Assessing the Efficacy & Safety of Hydroxychloroquine Sulfatein Patients With Syst ...
A Randomized, Double Blind, Baseline Controlled Study Using Placebo as Reference for Assessing the Efficacy and Safety of Hydroxychloroquine Sulfate in Patients With Systemic Lupus Erythematosus or Cutaneous Lupus Erythematosus in the Presence of Active Lupus Erythematosus Specific Skin Lesion A Randomized, Double Blind, Baseline Controlled Study Using Placebo as Reference for Assessing the E ...